GB9920910D0 - Novel chalcones - Google Patents

Novel chalcones

Info

Publication number
GB9920910D0
GB9920910D0 GBGB9920910.8A GB9920910A GB9920910D0 GB 9920910 D0 GB9920910 D0 GB 9920910D0 GB 9920910 A GB9920910 A GB 9920910A GB 9920910 D0 GB9920910 D0 GB 9920910D0
Authority
GB
United Kingdom
Prior art keywords
medicament
prevention
manufacture
useful
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9920910.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Priority to GBGB9920910.8A priority Critical patent/GB9920910D0/en
Publication of GB9920910D0 publication Critical patent/GB9920910D0/en
Priority to SI200030110T priority patent/SI1212315T1/xx
Priority to EP00964042A priority patent/EP1212315B1/en
Priority to SK311-2002A priority patent/SK3112002A3/sk
Priority to CZ2002787A priority patent/CZ2002787A3/cs
Priority to HU0202579A priority patent/HUP0202579A3/hu
Priority to AU75109/00A priority patent/AU776226B2/en
Priority to DK00964042T priority patent/DK1212315T3/da
Priority to CNB008123039A priority patent/CN1177843C/zh
Priority to DE60001851T priority patent/DE60001851T2/de
Priority to CA002382130A priority patent/CA2382130A1/en
Priority to PL00353064A priority patent/PL353064A1/xx
Priority to HK02105661.5A priority patent/HK1043999B/en
Priority to ES00964042T priority patent/ES2193106T3/es
Priority to AT00964042T priority patent/ATE235483T1/de
Priority to RU2002108566/04A priority patent/RU2252938C2/ru
Priority to PCT/EP2000/008366 priority patent/WO2001017988A1/en
Priority to PT00964042T priority patent/PT1212315E/pt
Priority to KR1020027002798A priority patent/KR100819576B1/ko
Priority to JP2001522211A priority patent/JP2003508527A/ja
Priority to US10/075,626 priority patent/US6620842B2/en
Priority to NO20021049A priority patent/NO20021049L/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GBGB9920910.8A 1999-09-03 1999-09-03 Novel chalcones Ceased GB9920910D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB9920910.8A GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones
JP2001522211A JP2003508527A (ja) 1999-09-03 2000-08-28 新規カルコン類
CA002382130A CA2382130A1 (en) 1999-09-03 2000-08-28 Novel chalcones
HK02105661.5A HK1043999B (en) 1999-09-03 2000-08-28 New chalcone
SK311-2002A SK3112002A3 (en) 1999-09-03 2000-08-28 Derivatives of chalcones, pharmaceutical composition comprising them and their use
CZ2002787A CZ2002787A3 (cs) 1999-09-03 2000-08-28 Nové chalkony
HU0202579A HUP0202579A3 (en) 1999-09-03 2000-08-28 Novel chalcones
AU75109/00A AU776226B2 (en) 1999-09-03 2000-08-28 Novel chalcones
DK00964042T DK1212315T3 (da) 1999-09-03 2000-08-28 Nye chalconer
CNB008123039A CN1177843C (zh) 1999-09-03 2000-08-28 新的查耳酮
DE60001851T DE60001851T2 (de) 1999-09-03 2000-08-28 Neue chalchone
SI200030110T SI1212315T1 (en) 1999-09-03 2000-08-28 Novel chalcones
PL00353064A PL353064A1 (en) 1999-09-03 2000-08-28 Novel chalcones
EP00964042A EP1212315B1 (en) 1999-09-03 2000-08-28 Novel chalcones
ES00964042T ES2193106T3 (es) 1999-09-03 2000-08-28 Nuevas chalconas.
AT00964042T ATE235483T1 (de) 1999-09-03 2000-08-28 Neue chalchone
RU2002108566/04A RU2252938C2 (ru) 1999-09-03 2000-08-28 Халконы и фармацевтическая композиция на их основе
PCT/EP2000/008366 WO2001017988A1 (en) 1999-09-03 2000-08-28 Novel chalcones
PT00964042T PT1212315E (pt) 1999-09-03 2000-08-28 Novas calconas
KR1020027002798A KR100819576B1 (ko) 1999-09-03 2000-08-28 신규 찰콘 화합물
US10/075,626 US6620842B2 (en) 1999-09-03 2002-02-15 Chalcones
NO20021049A NO20021049L (no) 1999-09-03 2002-03-01 Nye chalkoner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920910.8A GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones

Publications (1)

Publication Number Publication Date
GB9920910D0 true GB9920910D0 (en) 1999-11-10

Family

ID=10860346

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9920910.8A Ceased GB9920910D0 (en) 1999-09-03 1999-09-03 Novel chalcones

Country Status (21)

Country Link
US (1) US6620842B2 (https=)
EP (1) EP1212315B1 (https=)
JP (1) JP2003508527A (https=)
KR (1) KR100819576B1 (https=)
CN (1) CN1177843C (https=)
AT (1) ATE235483T1 (https=)
AU (1) AU776226B2 (https=)
CA (1) CA2382130A1 (https=)
CZ (1) CZ2002787A3 (https=)
DE (1) DE60001851T2 (https=)
DK (1) DK1212315T3 (https=)
ES (1) ES2193106T3 (https=)
GB (1) GB9920910D0 (https=)
HK (1) HK1043999B (https=)
HU (1) HUP0202579A3 (https=)
NO (1) NO20021049L (https=)
PL (1) PL353064A1 (https=)
PT (1) PT1212315E (https=)
RU (1) RU2252938C2 (https=)
SK (1) SK3112002A3 (https=)
WO (1) WO2001017988A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ536190A (en) 2002-04-17 2007-08-31 Cytokinetics Inc Compounds for treating cellular proliferative diseases by modulating the activity of the mitotic kinesin KSP
US7638554B2 (en) * 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US20030229136A1 (en) * 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
DE60326248D1 (de) 2002-07-17 2009-04-02 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
US6864264B1 (en) * 2002-08-20 2005-03-08 Gloria L. Anderson 1-adamantyl chalcones for the treatment of proliferative disorders
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
WO2013127361A1 (en) * 2012-03-01 2013-09-06 The Hong Kong Polytechnic University Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU634994B2 (en) * 1988-12-21 1993-03-11 Pharmacia & Upjohn Company Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
US5023341A (en) * 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
CA2084208A1 (en) * 1990-05-17 1991-11-18 Barry Markaverich Growth inhibitors and methods of treating cancer and cell proliferative diseases
IT1271301B (it) 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders

Also Published As

Publication number Publication date
CA2382130A1 (en) 2001-03-15
CN1371372A (zh) 2002-09-25
HUP0202579A2 (hu) 2002-11-28
SK3112002A3 (en) 2003-10-07
PT1212315E (pt) 2003-08-29
DE60001851D1 (de) 2003-04-30
CZ2002787A3 (cs) 2002-06-12
WO2001017988A1 (en) 2001-03-15
NO20021049L (no) 2002-05-03
AU776226B2 (en) 2004-09-02
KR100819576B1 (ko) 2008-04-22
HK1043999B (en) 2003-08-15
ES2193106T3 (es) 2003-11-01
EP1212315B1 (en) 2003-03-26
EP1212315A1 (en) 2002-06-12
US6620842B2 (en) 2003-09-16
AU7510900A (en) 2001-04-10
US20030055056A1 (en) 2003-03-20
HK1043999A1 (en) 2002-10-04
HUP0202579A3 (en) 2003-07-28
KR20020031598A (ko) 2002-05-02
DE60001851T2 (de) 2003-12-11
PL353064A1 (en) 2003-10-06
JP2003508527A (ja) 2003-03-04
RU2252938C2 (ru) 2005-05-27
ATE235483T1 (de) 2003-04-15
CN1177843C (zh) 2004-12-01
NO20021049D0 (no) 2002-03-01
DK1212315T3 (da) 2003-06-23

Similar Documents

Publication Publication Date Title
DE60038038D1 (en) Phosphonatverbindungen
IL188250A0 (en) Dosage unit for inhibiting ovulation comprising drospirenone and a complex between ethinyl estradiol and cyclodextrine
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
MXPA04004674A (es) Ligados de los receptors de los canabinodies.
BG105270A (en) Tetrahydropyridoethers
AP2000001898A0 (en) Vitronectin receptor antagonists
GB9920910D0 (en) Novel chalcones
PT989973E (pt) Calconas possuindo actividade antiproliferativa
CA2384433A1 (en) Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
WO2002020000A3 (en) Combined estrogen blockade of the breast with exemestane and raloxifene
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
EP0838461A3 (en) Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity
BG106428A (en) Pharmaceutical compositions for treating psoriasis
WO2003037269A3 (en) Di-, tri,- and tetra-peptides having antiangiogenic activity
ITBO990597A0 (it) Ortesi ortopedica per il trattamento di epicondiliti .
ES1039452U (es) Placa de osteotomia triple de cadera mejorada.
GR990200198U (en) Corset for protecting pelvis region from fractures
ZA200004651B (en) Xylitol compositions for treating upper respiratory conditions.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)